Cargando…
Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment
Diabetic macular edema (DME) is the most common cause of moderate visual loss in diabetic patients. The current treatment of choice for center-involved DME is anti-vascular endothelial growth factor (VEGF) treatment. Most patients that undergo pharmacological inhibition with anti-VEGF agents need mu...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947753/ https://www.ncbi.nlm.nih.gov/pubmed/31942427 http://dx.doi.org/10.4103/tjo.tjo_61_19 |